COV-IMMUNO - A RANDOMIZED, PHASE III TRIAL OF IMMUNIZATION WITH IMM-101 VERSUS OBSERVATION FOR THE PREVENTION OF SEVERE RESPIRATORY AND COVID-19 RELATED INFECTIONS IN CANCER PATIENTS AT INCREASED RISK OF EXPOSURE

Registry ID

IC.8

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

CANADIAN CANCER TRIALS GROUP, CANCER RESEARCH INSTITUTE, QUEEN'S UNIVERSITY

Start date

2020-11-12

Last update

2020-06-24

Conditions

• CANCER
• CORONAVIRUS DISEASE (COVID-19)

Related clinical trials

• ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers
• VEDOLIZUMAB FOR THE PREVENTION OF IMMUNE CHECKPOINT INHIBITOR RELATED TO DIARREA OR COLITIS IN PATIENTS WITH CANCER. A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
• TRIPTORELIN AND PROTECTION OF OVARIAN RESERVE IN ADOLESCENTS AND YOUNG ADULTS WITH CANCER
• ADAPTIVE PLATFORM TRIAL OF TREATMENTS FOR RESPIRATORY INFECTIONS IN COMMUNITY SETTINGS (TREATRESP)
• AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS
• OPTIMAL PRECISION THERAPIES TO CUSTOMISE CARE IN CHILDHOOD AND ADOLESCENT CANCER (OPTIMISE)

View on source registry